Why I Ride: Dr. Christopher Sweeney

Since 1980, more than 88,000 cyclists have taken to Massachusetts’ roads for the Pan-Mass Challenge (PMC) to raise funds for cancer research and patient care at Dana-Farber. Among the riders are many patients, their family members, and their doctors. Christopher Sweeney, MBBS, medical oncologist in Dana-Farber’s Lank Center for Genitourinary Oncology, is one of them. We recently spoke with Dr. Sweeney about what motivates him to ride.

Team Shawmut 2014 PMC

Christopher Sweeney, MBBS (left), joins Team Shawmut and PMC Founder and Executive Director Billy Starr (center) for the 2014 ride.

Why did you start riding the PMC?

In addition to treating patients with genitourinary cancers, particularly prostate and testicular cancer, I do clinical and translational research, with a focus on trying to find out why some patients relapse after treatment and others don’t. I receive funding from the National Institutes of Health and other government sources, but most of the funding that allows my research to really move forward comes from philanthropic support, like the PMC.

I was introduced to Team Shawmut [a team of 24 employees and supporters of Shawmut Design and Construction who have ridden since 2008] by a patient of mine who rides with the team. Several years ago, he suggested they direct the money they raise toward my research program. I also gave a speech before the 2013 ride, and this inspired me to get involved. Last year was my first ride. I’d never even owned a road bike before, but I rode with them for 192 miles over the course of two days. Mostly they rode ahead of me and I caught up, but I had a great time!

How does your PMC participation relate to your research at Dana-Farber?

The money we’ve raised through Team Shawmut has enabled my research team to collect testicular cancer tumor samples and analyze them with DFCI researchers, working in collaboration with the Broad Institute of Harvard and MIT to better understand which patients are likely to have recurrences. We’re hoping to identify these patients before they relapse so we can give them less intense, more effective treatment. This project is a huge team effort; we have medical oncologists and research fellows helping collect and annotate the specimens, pathologists to process the specimens, and a research team to analyze the samples. In the next few months we’ll have the first data set looking at the genes in testicular cancer patients who have been cured against those who have not.

Dr. Christopher Sweeney

Dr. Sweeney’s clinical and research focus is on testicular and prostate cancers.

Money raised through the PMC has also helped advance research related to my study showing that, for metastatic prostate cancer patients, chemotherapy plus hormonal therapy was more effective than hormonal therapy followed by chemotherapy. This study has changed the way we treat prostate cancer throughout the world, and additional studies analyzing why the combination is so effective would not be possible without philanthropic dollars.

What’s your favorite thing about the PMC?

Team Shawmut is a delightful group of people, including five patients of mine, and riding in the pace line with them is a great feeling. The camaraderie of the team is fantastic.

Participating in the ride has also helped me stay fit. I always talk to patients about the importance of exercise and wellness as part of their cancer care management, and now I’m practicing what I preach.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber clinicians have been involved in the development of several new agents approved recently for B-cell acu… https://t.co/Oo3SiY79EN
Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.